Search

everythinglearnresearchcommunity

for

Search:↓

SCF and c-Kit decrease in AGA hair follicles, possibly affecting hair pigmentation and growth.

Skin problems like acne, dry skin, and nail and hair changes are common in patients taking EGFR inhibitors.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Hormones, nutrition, and seasonal changes regulate hair growth cycles, with androgens extending growth phases and factors like aging and malnutrition affecting hair loss and thinning.

Valproic acid increases hair count in men with hair loss.

People with early onset baldness have higher bad cholesterol and lower good cholesterol, increasing their heart disease risk.

Metformin should be used for PCOS mainly in those with glucose intolerance, and has limited benefits for infertility or hirsutism.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

The document explains how to identify different hair problems using a microscope.

The document concludes that inherited epidermolysis bullosa is a challenging genetic condition requiring multidisciplinary care and new treatments.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Certain defective glucocorticoid receptor mutants move faster inside cell nuclei and work less effectively.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

The conclusion suggests a possible link between iron levels and hair health in women, recommending further research on iron supplementation for hair loss.

Women with excessive male-pattern hair growth should get a full hormone check-up to find and treat any underlying issues, considering both medical and emotional aspects.

Certain fats in the skin help control inflammation and health, and changing these fats through diet or supplements might treat skin inflammation.

The document concludes that dermal papilla cells are key for hair growth and could be used in new hair loss treatments.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.

Using neurohormones to control keratin can lead to new skin disease treatments.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Insulin resistance is linked to high male hormone levels in women, often seen in those with PCOS.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Using anabolic androgenic steroids can cause serious, lasting health problems in many parts of the body.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.